CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 37,700 shares at an average $6.91 ($260,457)
- 4 Open-market buy President and CEO bought 10,000 shares at $7.12 ($71,200)
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 4,622 shares (grant or award)
- 4 Grant or award Director acquired 100,000 shares (grant or award)
- 4 Grant or award Director acquired 3,081,664 shares (grant or award)
- 4 Grant or award Director acquired 770,416 shares (grant or award)
- 4 Grant or award President and CEO acquired 20,000 shares (grant or award)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
Page 45 of 62 · 1,224 filings